Product Recalls in South Dakota

Product recalls affecting South Dakota — including food, drugs, consumer products, medical devices, and vehicles distributed to South Dakota. RecallDetector monitors distribution data from the FDA, USDA, CPSC, and NHTSA to show you which recalls are relevant to your area. 2,429 recalls have been distributed to South Dakota in the last 12 months.

47,632 total recalls
2,429 in last 12 months

Showing 1776117780 of 47,632 recalls

DrugMay 29, 2020· Amneal Pharmaceuticals of New York, LLC

Recalled Item: amneal Metformin Hydrochloride Extended-Release Tablets Recalled by Amneal...

The Issue: CGMP Deviations: FDA analysis detected N-Nitrosodimethylamine (NDMA)...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMay 29, 2020· Amneal Pharmaceuticals of New York, LLC

Recalled Item: amneal Metformin Hydrochloride Extended-Release Tablets Recalled by Amneal...

The Issue: CGMP Deviations: FDA analysis detected N-Nitrosodimethylamine (NDMA)...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMay 29, 2020· Amneal Pharmaceuticals of New York, LLC

Recalled Item: amneal Metformin Hydrochloride Extended-Release Tablets Recalled by Amneal...

The Issue: CGMP Deviations: FDA analysis detected N-Nitrosodimethylamine (NDMA)...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMay 29, 2020· Amneal Pharmaceuticals of New York, LLC

Recalled Item: amneal Metformin Hydrochloride Extended-Release Tablets Recalled by Amneal...

The Issue: CGMP Deviations: FDA analysis detected N-Nitrosodimethylamine (NDMA)...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMay 29, 2020· Amneal Pharmaceuticals of New York, LLC

Recalled Item: amneal Metformin Hydrochloride Extended-Release Tablets Recalled by Amneal...

The Issue: CGMP Deviations: FDA analysis detected N-Nitrosodimethylamine (NDMA)...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMay 29, 2020· Amneal Pharmaceuticals of New York, LLC

Recalled Item: amneal Metformin Hydrochloride Extended-Release Tablets Recalled by Amneal...

The Issue: CGMP Deviations: FDA analysis detected N-Nitrosodimethylamine (NDMA)...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMay 29, 2020· Amneal Pharmaceuticals of New York, LLC

Recalled Item: amneal Metformin Hydrochloride Extended-Release Tablets Recalled by Amneal...

The Issue: CGMP Deviations: FDA analysis detected N-Nitrosodimethylamine (NDMA)...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMay 29, 2020· Amneal Pharmaceuticals of New York, LLC

Recalled Item: amneal Metformin Hydrochloride Extended-release Tablets Recalled by Amneal...

The Issue: CGMP Deviations: FDA analysis detected N-Nitrosodimethylamine (NDMA)...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMay 29, 2020· Amneal Pharmaceuticals of New York, LLC

Recalled Item: amneal Metformin Hydrochloride Extended-Release Tablets Recalled by Amneal...

The Issue: CGMP Deviations: FDA analysis detected N-Nitrosodimethylamine (NDMA)...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMay 29, 2020· Amneal Pharmaceuticals of New York, LLC

Recalled Item: amneal Metformin Hydrochloride Extended-release Tablets Recalled by Amneal...

The Issue: CGMP Deviations: FDA analysis detected N-Nitrosodimethylamine (NDMA)...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMay 29, 2020· Amneal Pharmaceuticals of New York, LLC

Recalled Item: amneal Metformin Hydrochloride Extended-Release Tablets Recalled by Amneal...

The Issue: CGMP Deviations: FDA analysis detected N-Nitrosodimethylamine (NDMA)...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMay 29, 2020· Amneal Pharmaceuticals of New York, LLC

Recalled Item: amneal Metformin Hydrochloride Extended-release Tablets Recalled by Amneal...

The Issue: CGMP Deviations: FDA analysis detected N-Nitrosodimethylamine (NDMA)...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMay 29, 2020· Pfizer Inc.

Recalled Item: Unasyn (ampicillin sodium/sulbacatam) for injection Recalled by Pfizer Inc....

The Issue: Presence of Particulate Matter: particulate matter identified after...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
Medical DeviceMay 29, 2020· TELEFLEX MEDICAL INC

Recalled Item: RUSCH LASERTUBE (Rubber) Recalled by TELEFLEX MEDICAL INC Due to Teleflex is...

The Issue: Teleflex is initiating a voluntary recall for the above-mentioned products...

Recommended Action: Stop using. Contact the manufacturer or your healthcare provider.

Class II — Potential Health HazardOngoing
DrugMay 28, 2020· Glaxosmithkline Consumer Healthcare Holdings

Recalled Item: Gaviscon Regular Strength Liquid Antacid Cool Mint Recalled by...

The Issue: Labeling: Label lacks warning - Magnesium safety warning is not present on...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMay 28, 2020· Glaxosmithkline Consumer Healthcare Holdings

Recalled Item: Gaviscon Extra Strength Liquid Antacid Extra Strength Cherry Recalled by...

The Issue: Labeling: Label lacks warning - Magnesium safety warning is not present on...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMay 28, 2020· Glaxosmithkline Consumer Healthcare Holdings

Recalled Item: Gaviscon Liquid Antacid Extra Strength Recalled by Glaxosmithkline Consumer...

The Issue: Labeling: Label lacks warning - Magnesium safety warning is not present on...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMay 28, 2020· Glaxosmithkline Consumer Healthcare Holdings

Recalled Item: Gaviscon Regular Strength Liquid Antacid Cool Mint Recalled by...

The Issue: Labeling: Label lacks warning - Magnesium safety warning is not present on...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMay 28, 2020· QuVa Pharma, Inc.

Recalled Item: oxyTOCIN 30 Units/500 mL (0.06 Units/mL) added to 0.9% Sodium Recalled by...

The Issue: Subpotent drug - Product did not contain drug.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMay 28, 2020· Lupin Pharmaceuticals Inc.

Recalled Item: Lisinopril Tablets Recalled by Lupin Pharmaceuticals Inc. Due to Product Mix...

The Issue: Product Mix Up: Lisinopril 10 mg tablets were found in Lisinopril 5 mg...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund